Tag: venous stenting

Abhishek Mohapatra

Deep venous stenting presents advantage over ablation in achieving better ulcer...

“Venous leg ulcers (VLUs) secondary to deep venous stenosis represents a distinct class of patients who require a unique treatment paradigm,” stated Abhisekh Mohapatra...
Arjun Jayaraj

Contralateral limb improvement after unilateral iliac vein stenting argues against simultaneous...

A retrospective review of patients presenting with bilateral obstructive iliofemoral venous lesions has shown that contralateral limb symptoms improve following stenting of the worse...
Michael Lichtenberg 766x512

IVUS helps to reduce radiation exposure “significantly” for patients undergoing venous...

 Michael Lichtenberg (Arnsberg, Germany) talks to BLearning Venous at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the rationale behind his...
Michael Lichtenberg

Mid-term follow-up data for venous stent confirms high patency in line...

Clinical outcomes with the Vici venous stent system (Boston Scientific) have been described as “very good”, according to a presentation of 24- and 36-month...
Kolluri Kaufman

VIVA 2019: Competition in the venous stenting space “will ultimately benefit...

 Raghu Kolluri (Columbus, USA) and John Kaufman (Portland, USA) talk to BLearning Venous about the highlights from The VEINS (Venous Endovascular INterventional Strategies) session...
Vest-stent

VEST external stent demonstrates low event and disease rates in two...

Clinical data presented at the 2019 European Cardio-Thoracic Surgery (EACTS) annual meeting (3-5 October, Lisbon, Portugal), from two prospective trials of the VEST external...
Adam Gwozdz

Thrombophilia not an independent risk factor for venous stent patency loss...

A recent study has concluded that patients with inherited or acquired thrombophilia should not be excluded from ilio-femoral venous stenting, Adam Gwozdz (St Thomas’...

Vesper Medical announces US$37 million financing with Vensana Capital and Gilde...

Vesper Medical, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced a US$37 million financing with Vensana Capital and Gilde...

VIRTUS 12-month outcomes presented at LINC: Vici stent meets primary endpoints

New 12-month data from the VIRTUS trial demonstrates that patients who were treated with the Vici Venous Stent system (Boston Scientific) for iliac and femoral...
Michael Dake

VERNACULAR trial 12-month data show successful use of Venovo stent in...

The 12-month results from the VERNACULAR trial have shown that the Venovo venous stent (BD Interventional) is successful when deployed in obstructive iliac and...
Venous News for specialists

Worse outcomes in peripartum compared to non-pregnant women stented for DVT

Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...

New intravascular ultrasound-based scoring system may predict future venous stent failure

To accompany the growing importance of intravascular ultrasound (IVUS) as an adjuvant diagnostic tool when treating deep venous disease, a study sought to create...

Reviewing five years of deep venous stenting: What comes next?

For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...

Use of IVUS to optimise outcomes in venous stenting

Intravascular ultrasound (IVUS) imaging technology provides the current gold standard technique for detection and characterisation of venous disease, Erin Murphy writes. In this article,...
UIP 2018

UIP audience votes against stenting as standard for deep vein obstruction

The deep venous world is wrestling with the question: To stent or not to stent. While the availability of new specialised venous stents is...

First-in-man usage of blueflow venous stent

Following the announcement of receiving the CE mark in early 2018, ab medica has now reported the first-in man usage of its blueflow Venous...

One-year data from venous stent registry “promising”

Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent. Presenting the data at...
Abre

IDE study to evaluate Abre Venous Self-Expanding Stent in patients with...

Medtronic has announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will...

Identifying standard practices of antithrombotic therapy post-venous stenting

Venous stenting has evolved over the last 15 years, quickly becoming an established procedure, with Class II recommendations from the American Heart Association and...

New research indicates that stenting below the inguinal ligament does not...

Endovascular treatment of iliocaval and infrainguinal post-thrombotic venous obstruction results do not appear to be adversely affected by extension of the iliac vein stents...
Adam Gwozdz

Decision-making in the choice of anticoagulants following deep venous stenting

Deep venous stenting has become increasingly used to treat patients with pathological obstruction of venous return in the femoro-iliocaval venous segment following the development of new...